Skip to main content
HairCited

아연 관련 휴지기 탈모증

F 효과 연구에 따르면 이 용도에 효과가 있을 가능성은 낮은 것으로 나타납니다.

총 30,246명의 참여자를 대상으로 한 29건의 연구(RCT 3건)에 근거합니다. 연구 결과는 혼재되어 있습니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dzinc\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

F

결론

Moderate evidence suggests that zinc deficiency may contribute to telogen effluvium, and supplementation may help if levels are low — but routine zinc supplementation for hair shedding is not clearly supported.

  • Lower zinc levels are frequently found in telogen effluvium patients
  • Some RCTs show benefits from zinc-containing supplement combinations
  • Difficult to isolate zinc's specific effect from multi-ingredient formulas
  • Testing zinc levels and supplementing only if deficient is a reasonable approach

Key Study Findings

Prospective Open-Label Interventional Study n=343 4 weeks Open-label
Effect of a Hydrolyzed Collagen, Vitamin, and Zinc Containing Nutritional Supplement on Telogen Effluvium.
Dose: Pilopeptan Intensive (hydrolyzed collagen, Group B vitamins, zinc); daily for 1 month vs: Placebo 효과: Significant improvements in all hair parameters at T1 and T2 (P < 0.001) p<0.001
Retrospective Cross-Sectional Study n=23975
Hair Loss and Zinc Deficiency: A Cross-Sectional Study.
Dose: None vs: Placebo 효과: Median zinc 96 µg/dL (hair loss) vs 99 µg/dL (control); statistically significant but clinically min p<0.001
cross-sectional study
Zinc Status in Kurdish Adults With Hair Loss.
Dose: None vs: Placebo 효과: None None
Case-Control Study n=100
Role of zinc in chronic telogen effluvium in serum and hair of patients with alopecia.
Dose: None vs: Placebo 효과: None 0.05

Key Statistics

32

연구

30246

참여자

Mixed

F

등급

Referenced Papers

Healthcare (Basel, Switzerland) 2025
Journal of drugs … 2021 3 인용
Acta dermatovenerologica Croatica … 2016 6 인용
Annals of dermatology 2013 114 인용
Dermatologic therapy 2012 31 인용
American journal of … 2005 140 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
8-11 mg/day
hairloss:
15-30 mg/day

상한량: 40 mg/day

연구에서 사용된 용량

용량 기간 효과 N
Pilopeptan Intensive (hydrolyzed collagen, Group B vitamins, zinc); daily for 1 month 4 weeks Positive 343
None -- Neutral 23975
None -- Neutral --
None -- Negative 100
not applicable -- Mixed 180
None -- Mixed 100
None -- Mixed --
4 tablets daily (arginine, l-cystine, zinc, vitamin B6) 12 weeks Positive 20

권장 복용 시간: With meals to minimize stomach upset; separate from iron and calcium by 2 hours

Safety & Side Effects

보고된 부작용

  • Nausea and vomiting (especially on an empty stomach)
  • Metallic taste in the mouth
  • Copper depletion with chronic high-dose use
  • Headache and diarrhea

알려진 상호작용

  • Copper supplements (zinc inhibits copper absorption at doses >40 mg/day)
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Penicillamine (zinc reduces absorption of this rheumatoid arthritis drug)

일일 최대 섭취 허용량: 40 mg/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 아연 help with 휴지기 탈모증?
Based on 32 studies with 30,246 participants, there is insufficient evidence at this time that 아연 may support 휴지기 탈모증 management. Our evidence grade is F (Evidence Against).
How much 아연 should I take for 휴지기 탈모증?
Studies have used various dosages. A commonly studied range is 8-11 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 아연?
Reported side effects may include Nausea and vomiting (especially on an empty stomach), Metallic taste in the mouth, Copper depletion with chronic high-dose use, Headache and diarrhea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 아연 and 휴지기 탈모증?
We rate the evidence as Grade F (Evidence Against). This rating is based on 32 peer-reviewed studies with 30,246 total participants. The overall direction of effect is mixed.

References

  1. [1] Eva María Arias et al.. Int J Trichology. 2025. Effect of a Hydrolyzed Collagen, Vitamin, and Zinc Containing Nutritional Supplement on Telogen Effluvium. doi:10.4103/ijt.ijt_70_24 PubMed
  2. [2] Ori Liran et al.. Healthcare (Basel). 2025. Hair Loss and Zinc Deficiency: A Cross-Sectional Study. doi:10.3390/healthcare13222965 PubMed
  3. [3] Irem Nur Durusu Turkoglu et al.. J Cosmet Dermatol. 2024. A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … doi:10.1111/jocd.16512 PubMed
  4. [4] Nermeen Ibrahim Bedair et al.. Arch Dermatol Res. 2024. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case … doi:10.1007/s00403-024-03004-1 PubMed
  5. [5] Shayan Zufishan et al.. J Pak Med Assoc. 2024. Role of zinc in chronic telogen effluvium in serum and hair of patients with alopecia. doi:10.47391/JPMA-DUHS-S10 PubMed
  6. [6] Rhiannon C Miller et al.. Arch Dermatol Res. 2024. Cost-effectiveness analysis of laboratory monitoring in newly diagnosed telogen effluvium patients. doi:10.1007/s00403-024-02948-8 PubMed
  7. [7] Hivi Mahmoud et al.. Cureus. 2024. Zinc Status in Kurdish Adults With Hair Loss. doi:10.7759/cureus.67264 PubMed
  8. [8] Rhiannon C Miller et al.. J Am Acad Dermatol. 2023. "Shedding" low yield testing for telogen effluvium: A cross-sectional study of 16,381 laboratory results from newly diagnosed patients. doi:10.1016/j.jaad.2023.05.045 PubMed
  9. [9] Hakan Arslan et al.. Dermatol Pract Concept. 2023. Micronutrient Deficiencies and Digital Computerized Phototrichogram Analysis in Telogen Effluvium: a Retrospective Correlation Study in a Tertiary Medical Center. doi:10.5826/dpc.1303a202 PubMed
  10. [10] Michela Starace et al.. Ital J Dermatol Venerol. 2023. Clinical study on the efficacy and tolerability of an oral supplement based on arginine, l-cystine, zinc and B6 vitamin (Cystiphane®) … doi:10.23736/S2784-8671.23.07576-X PubMed
  11. [11] Michela Starace et al.. Ital J Dermatol Venerol. 2023. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic … doi:10.23736/S2784-8671.22.07416-3 PubMed
  12. [12] Ahu Yorulmaz et al.. J Cosmet Dermatol. 2022. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. doi:10.1111/jocd.14413 PubMed
  13. [13] Noor Altooq et al.. Hum Nutr Metab. 2022. The role of micronutrients in the management of COIVD-19 and optimizing vaccine efficacy. doi:10.1016/j.hnm.2022.200141 PubMed
  14. [14] Elizabeth J Klein et al.. JAAD Int. 2022. Supplementation and hair growth: A retrospective chart review of patients with alopecia and laboratory abnormalities. doi:10.1016/j.jdin.2022.08.013 PubMed
  15. [15] Mohammed Al Abadie et al.. Dermatol Reports. 2022. Possible relationship between poor skin disorders prognosis and serum zinc level: A narrative review. doi:10.4081/dr.2022.9512 PubMed
  16. [16] Alfredo Rossi et al.. Ital J Dermatol Venerol. 2022. A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study. doi:10.23736/S2784-8671.21.06915-7 PubMed
  17. [17] Efe Kakpovbia et al.. J Drugs Dermatol. 2021. Laboratory Testing in Telogen Effluvium. doi:10.36849/JDD.5771 PubMed
  18. [18] Flávia Alvim Sant'Anna Addor et al.. Clin Cosmet Investig Dermatol. 2018. Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium. doi:10.2147/CCID.S173082 PubMed
  19. [19] Ibrahim Halil Yavuz et al.. Indian J Dermatol. 2018. Assessment of Heavy Metal and Trace Element Levels in Patients with Telogen Effluvium. doi:10.4103/ijd.IJD_610_17 PubMed
  20. [20] Dinesh Gowda et al.. Int J Trichology. 2017. Prevalence of Nutritional Deficiencies in Hair Loss among Indian Participants: Results of a Cross-sectional Study. doi:10.4103/ijt.ijt_48_16 PubMed
  21. [21] Evelyn J Cheung et al.. J Drugs Dermatol. 2016. Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study. PubMed
  22. [22] Tee Wei Siah et al.. Int J Trichology. 2016. Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. doi:10.4103/0974-7753.188033 PubMed
  23. [23] Jana Zímová et al.. Acta Dermatovenerol Croat. 2016. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. PubMed
  24. [24] Abeer M Abdel Aziz et al.. Int J Trichology. 2015. Possible Relationship between Chronic Telogen Effluvium and Changes in Lead, Cadmium, Zinc, and Iron Total Blood Levels in Females: A … doi:10.4103/0974-7753.167465 PubMed
  25. [25] Thamer Mubki. J Cutan Med Surg. 2014. Use of Vitamins and Minerals in the Treatment of Hair Loss: A Cross-Sectional Survey among Dermatologists in Saudi Arabia. doi:10.2310/7750.2014.14008 PubMed
  26. [26] Min Seong Kil et al.. Ann Dermatol. 2013. Analysis of serum zinc and copper concentrations in hair loss. doi:10.5021/ad.2013.25.4.405 PubMed
  27. [27] Khitam Al-Refu. Int J Trichology. 2013. Hair loss in children: common and uncommon causes; clinical and epidemiological study in jordan. doi:10.4103/0974-7753.130393 PubMed
  28. [28] Tadashi Karashima et al.. Dermatol Ther. 2012. Oral zinc therapy for zinc deficiency-related telogen effluvium. doi:10.1111/j.1529-8019.2012.01443.x PubMed
  29. [29] C Durusoy et al.. Clin Exp Dermatol. 2009. The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control … doi:10.1111/j.1365-2230.2008.03165.x PubMed
  30. [30] Leonid Benjamin Trost et al.. J Am Acad Dermatol. 2006. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. doi:10.1016/j.jaad.2005.11.1104 PubMed
  31. [31] Renata Strumia. Am J Clin Dermatol. 2005. Dermatologic signs in patients with eating disorders. doi:10.2165/00128071-200506030-00003 PubMed
  32. [32] C Piérard-Franchimont et al.. Int J Cosmet Sci. 2002. Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. doi:10.1046/j.1467-2494.2002.00145.x PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.